Everolimus with paclitaxel and carboplatin as first-line treatment for metastatic large-cell neuroendocrine lung carcinoma: a multicenter phase II trial
AbstractBackground. Large-cell neuroendocrine carcinoma of the lung (LCNEC) is a rare disease with poor prognosis and limited treatment options. Neuroendocrine
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
23 May 2017
|
| In: |
Annals of oncology
Year: 2017, Volume: 28, Issue: 8, Pages: 1898-1902 |
| ISSN: | 1569-8041 |
| DOI: | 10.1093/annonc/mdx268 |
| Online Access: | Verlag, Volltext: http://dx.doi.org/10.1093/annonc/mdx268 Verlag, Volltext: https://academic.oup.com/annonc/article/28/8/1898/3848908 
|
| Author Notes: | P. Christopoulos, W. Engel-Riedel, C. Grohé, C. Kropf-Sanchen, J. von Pawel, S. Gütz, J. Kollmeier, W. Eberhardt, D. Ukena, V. Baum, I. Nimmrich, C. Sieder, P. A. Schnabel, M. Serke & M. Thomas |
| Summary: | AbstractBackground. Large-cell neuroendocrine carcinoma of the lung (LCNEC) is a rare disease with poor prognosis and limited treatment options. Neuroendocrine |
|---|---|
| Item Description: | Gesehen am 20.07.2018 |
| Physical Description: | Online Resource |
| ISSN: | 1569-8041 |
| DOI: | 10.1093/annonc/mdx268 |